Table 1.
Published studies of capsaicin for CHS in the ED.
Study | Design | Population | Main findings/conclusions |
---|---|---|---|
Biary et al. (2014) [3] (n = 1) | Case report | Adult | Resolution of N/V and abdominal cramping after 20–30 min |
Lapoint J. (2014) [4] (n = 2) | Case series (abstract only) | Adolescent and adult aged 19 and 29 yo | Capsaicin cream associated with decrease in pain score from 8 to 4/10 and 3/10, respectively |
Lapoint J. (2014) [4] (n = 5) | Case series (abstract only) | Adult | Resolution of nausea, vomiting, and pain within 22–45 min of administration of capsaicin |
Roman et al. (2016) [6] (n = 1) | Case report | Adult | Metoclopramide and granisetron ineffective. Resolution of symptoms after application of capsaicin |
Dezieck et al. (2017) [7] (n = 13) | Case series | Adults and adolescent aged 19 (n = 1) to 47 yo | Reported relief of symptoms within 45 min after administration of capsaicin cream |
McCloskey et al. (2017)[8] (n = 22) | Retrospective cohort series (abstract only) | Ages unknown | Capsaicin associated longer emergency department length of stay (non-significant) |
Graham et al. (2017) [9] (n = 2) | Case series | Adolescents aged 16 and 20 yo | Capsaicin associated with improvement in symptoms of nausea and abdominal pain |
Hafez et al. (2017) [10] (n = 4) | Case series (abstract only) | Ages unknown | Patients discharged within hours of receiving capsaicin (also received ondansetron and prochlorperazine) |
Moon et al. (2018) [11] (n = 1) | Case report (abstract only) | Adult | Partial resolution of symptoms after first application, complete resolution after 2 additional doses of capsaicin |
Sharma U et al. (2018) [12] (n = 1) | Case report | Adult | 4-day hospital admission; Droperidol, antacids, PPI’s and capsaicin associated with symptom improvement |
Wagner et al. (2020) [13] (n = 43) | Retrospective cohort review | Adult | No significant difference in ED LOS when capsaicin was utilized for CHS 179 vs 201 min (p = 0.33) |